Center-Authored Papers

Filters: Author is Goss, Paul E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2011
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
2013
Sgroi DC, Carney E, Zarrella E, Steffel L, Binns SN, Finkelstein DM, Szymonifka J, Bhan AK, Shepherd LE, Zhang Y et al..  2013.  Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker.. Journal of the National Cancer Institute. 105(14):1036-1042. Abstract
2014
Goss PE, Hershman DL, Cheung AM, Ingle JN, Khosla S, Stearns V, Chalchal H, Rowland K, Muss HB, Linden HM et al..  2014.  Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial.. The lancet oncology. 15(4):474-82. Abstract
257
Sgroi DC, Carney E, Zarrella E, Steffel L, Binns SN, Finkelstein DM, Szymonifka J, Bhan AK, Shepherd LE, Zhang Y et al..  2013.  Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker.. Journal of the National Cancer Institute. 105(14):1036-1042. Abstract
Adult
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Aged
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Aged, 80 and over
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Androstadienes
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
April 2014
Goss PE, Hershman DL, Cheung AM, Ingle JN, Khosla S, Stearns V, Chalchal H, Rowland K, Muss HB, Linden HM et al..  2014.  Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial.. The lancet oncology. 15(4):474-82. Abstract
Aromatase Inhibitors
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Breast Neoplasms
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Carcinoma, Intraductal, Noninfiltrating
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Center-Authored Paper
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Clinical Research Division
Goss PE, Hershman DL, Cheung AM, Ingle JN, Khosla S, Stearns V, Chalchal H, Rowland K, Muss HB, Linden HM et al..  2014.  Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial.. The lancet oncology. 15(4):474-82. Abstract
Double-Blind Method
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Female
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Follow-Up Studies
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Humans
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Incidence
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
July 2013
Sgroi DC, Carney E, Zarrella E, Steffel L, Binns SN, Finkelstein DM, Szymonifka J, Bhan AK, Shepherd LE, Zhang Y et al..  2013.  Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker.. Journal of the National Cancer Institute. 105(14):1036-1042. Abstract
Middle Aged
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Neoplasm Invasiveness
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Postmenopause
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Prevention Center Core Facility
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract
Public Health Sciences Division
Goss PE, Ingle JN, Alés-Martínez JE, Cheung AM, Chlebowski RT, Wactawski-Wende J, McTiernan A, Robbins J, Johnson KC, Martin LW et al..  2011.  Exemestane for breast-cancer prevention in postmenopausal women.. The New England journal of medicine. 364(25):2381-91. Abstract